TY - JOUR
KW - Buprenorphine/therapeutic use
KW - COVID-19
KW - Health Services Accessibility
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - New York
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/rehabilitation
KW - Primary Health Care
KW - Rural Population
KW - Telemedicine/trends
KW - Urban Population
KW - buprenorphine
KW - Telemedicine
AU - L. Wang
AU - J. Weiss
AU - E. B. Ryan
AU - J. Waldman
AU - S. Rubin
AU - J. L. Griffin
A1 - 
AD - Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program, Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America. Electronic address: Linda.wang2@mountsinai.org.; Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program, Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.; REACH Medical, Ithaca, NY, United States of America.; REACH Medical, Ithaca, NY, United States of America.; Respectful and Equitable Access to Comprehensive Healthcare (REACH) Program, Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.; REACH Medical, Ithaca, NY, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
DO - 10.1016/j.jsat.2020.108272
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PY - 2021
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108272
T1 - Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
T2 - Journal of substance abuse treatment
TI - Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
U1 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
U2 - 33771276
U3 - 10.1016/j.jsat.2020.108272
VL - 124
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2021
Y2 - May
ER -